Blueprint Medicines is Drug Discovery in United States that focus on Blueprint Medicines Corp business. Founded in 2008. They cover business area such as Blueprint Medicines Corp, patient, disease, abnormal kinase activation, cancer, its drug candidate, KIT Exon, abnormally active receptor tyrosine kinase mutant, driver, proliferative disorder, its other drug candidate, BLU, Advanced Hepatocellular Carcinoma, Ret Mutations, Fusions, Predicted, Resistant Mutants.
2008
( 16 years old in 2024 )
Blueprint Medicines Corp
-
45 Sidney Street
Cambridge, MA 02139
United States
Private
Blueprint Medicines Corppatientdiseaseabnormal kinase activationcancerits drug candidateKIT Exonabnormally active receptor tyrosine kinase mutantdriverproliferative disorderits other drug candidateBLUAdvanced Hepatocellular CarcinomaRet MutationsFusionsPredictedResistant Mutants
* We use standard office opening hours in near Blueprint Medicines's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Blueprint Medicines is Drug Discovery business from United States that founded in 2008 (16 years old in 2024), Blueprint Medicines business is focusing on Blueprint Medicines Corp.
Blueprint Medicines headquarter office and corporate office address is located in 45 Sidney Street Cambridge, MA 02139 United States.
Blueprint Medicines was founded in United States.
In 2024, Blueprint Medicines is currently focus on Blueprint Medicines Corp sector.
Above is snippet of Google Trends for "Blueprint Medicines Corp" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Blueprint Medicines, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
